Indian Cefixime Exporters: Complete Supplier Ranking with Market Share — 668 Manufacturers (2026) — TransData Nexus

Q: Who is the largest cefixime supplier from India?

MICRO LABS LIMITED is the largest cefixime exporter from India with a 11.0% market share and export value of $19.1M.

Q: How many cefixime suppliers are there in India?

There are 668 active cefixime exporters in India, collectively shipping $173.9M worth of cefixime across 8,398 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top cefixime suppliers from India?

The top 5 cefixime suppliers from India — MICRO LABS LIMITED, LUPIN LIMITED, AUROBINDO PHARMA LTD, UNIVENTIS MEDICARE LIMITED, SAKAR HEALTHCARE LIMITED — together control 30.4% of total cefixime export value from India.

Suresh Sormare

Cefixime

India Pharmaceutical Trade Intelligence

$173.9M668 Suppliers131 CountriesHS 30042019

ExportsIndia → FRANCE11.3%India → UNITED STATES7.1%

ImportsUNITED STATES → India$68.6K AUSTRIA → India$16.7K

#1 Supplier: MICRO LABS #1 Buyer: SAAM GROUP

Cefixime Suppliers from India (2026) — 668 Exporters, $173.9M Market | TransData Nexus | TransData Nexus

Who Exports Cefixime from India — 668 Suppliers Behind a $173.9M Market

India's cefixime export market is supplied by 668 active exporters who collectively shipped $173.9M across 8,398 shipments. MICRO LABS LIMITED leads with a 11.0% market share, followed by LUPIN LIMITED and AUROBINDO PHARMA LTD. The top 5 suppliers together control 30.4% of total export value, reflecting a moderately competitive market structure.

Source: Indian Customs (DGFT)·Published March 2026·

India's Top Cefixime Suppliers & Exporters — 668 manufacturers, $173.9M export market, top destinations and formulations — Cefixime supplier data — 668 exporters · $173.9M market · 8,398 shipmentsTransData Nexus · Indian Customs Data

Top Cefixime Exporters from India — Ranked by Export Value

MICRO LABS LIMITED is the leading cefixime exporter from India, holding a 11.0% share of the $173.9M market across 8,398 shipments from 668 exporters. The top 5 suppliers — MICRO LABS LIMITED, LUPIN LIMITED, AUROBINDO PHARMA LTD, UNIVENTIS MEDICARE LIMITED, SAKAR HEALTHCARE LIMITED — collectively control 30.4% of total export value, indicating a competitive market. Individual shares are: MICRO LABS LIMITED (11.0%), LUPIN LIMITED (6.4%), AUROBINDO PHARMA LTD (4.6%), UNIVENTIS MEDICARE LIMITED (4.4%), SAKAR HEALTHCARE LIMITED (4.1%).

Top Cefixime Exporters from India

Ranked by export value · 668 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Cefixime Exporters from India — Ranked by Export Value. 668 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1	MICRO LABS LIMITED

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Cefixime exporters

Certification and compliance status for top Cefixime suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Micro Labs Limited	Approved	Yes, as of December	No	11	WHO-GMP certified; 11 ANDAs approved by FDA as of 2023.
Lupin Limited	Approved	Yes	No	15	WHO-GMP certified; 15 ANDAs approved by FDA as of 2023.
Aurobindo Pharma Ltd	Approved	Yes	No	41	WHO-GMP certified; 41 ANDAs approved by FDA as of 2023.
Macleods Pharmaceuticals Ltd	Approved	Yes, as of February	No	10	WHO-GMP certified; 10 ANDAs approved by FDA as of 2023.
Fourrts (India) Laboratories Private Limited	Not Listed	Yes	No	Not Listed	WHO-GMP certified.
Sakar Healthcare Limited	Not Listed	Yes	No	Not Listed	WHO-GMP certified.
Saga Lifesciences Limited	Not Listed	Yes	No	Not Listed	WHO-GMP certified.
Ajanta Pharma Limited	Approved	Yes	No	9	WHO-GMP certified; 9 ANDAs approved by FDA as of 2023.

TransData Nexus reviewed the regulatory standing of 8 leading Cefixime exporters from India. 5 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 0 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Cefixime sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for the production of Active Pharmaceutical Ingredients (APIs), including Cefixime. The city's pharmaceutical industry is bolstered by a robust infrastructure, skilled workforce, and supportive government policies. Companies like Bhasya International Pvt Ltd, based in Hyderabad, specialize in manufacturing APIs and intermediates, contributing significantly to the Cefixime supply chain.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations, encompassing the production of finished dosage forms of antibiotics like Cefixime. This region hosts numerous WHO-GMP certified facilities, ensuring adherence to international quality standards. For instance, Taj Pharma India, located in Vapi, Gujarat, manufactures Cefixime 400mg capsules, emphasizing quality and global distribution.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a crucial export gateway for pharmaceutical products, including Cefixime. Mumbai, being a major port city, facilitates seamless international trade. Companies like Cipla, headquartered in Mumbai, leverage this strategic location to distribute their products globally.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Cefixime exporters from India

January 2025

M&A

Aurobindo Pharma Limited — Aurobindo Pharma acquires remaining stake in GLS Pharma

In early 2025, Aurobindo Pharma finalized its acquisition of GLS Pharma by purchasing the remaining 49% stake, achieving full ownership of the Hyderabad-based oncology company. This move enhances Aurobindo's capabilities in oncology APIs and formulations, including injectables and oral cancer therapies. - IMPACT: The acquisition is expected to strengthen Aurobindo's oncology portfolio, potentially increasing its Cefixime export capacity.

Impact: The acquisition is expected to strengthen Aurobindo's oncology portfolio, potentially increasing its Cefixime export capacity.

March 2024

Regulatory

Aurobindo Pharma Limited — US FDA issues Form 483 with seven observations to Aurobindo's Telangana plant

In March 2024, the US FDA issued a Form 483 with seven observations to Aurobindo Pharma's Telangana manufacturing facility. The observations included inadequate procedures to prevent contamination, insufficient training for employees, and lack of proper equipment placement. - IMPACT: Addressing these regulatory concerns may temporarily affect Aurobindo's production and export of Cefixime.

Impact: Addressing these regulatory concerns may temporarily affect Aurobindo's production and export of Cefixime.

Common Questions — Cefixime Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which cefixime supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, MICRO LABS LIMITED leads with 697 recorded shipments worth $19.1M. LUPIN LIMITED (83 shipments) and AUROBINDO PHARMA LTD (192 shipments) are also established high-volume exporters.

Q How many cefixime manufacturers are there in India?

India has 668 active cefixime exporters with a combined export market of $173.9M across 8,398 shipments to 131 countries. The top 5 suppliers hold 30.4% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Cefixime

Cefixime

Who Exports Cefixime from India — 668 Suppliers Behind a $173.9M Market

Top Cefixime Exporters from India — Ranked by Export Value

Top Cefixime Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Aurobindo Pharma Limited — Aurobindo Pharma acquires remaining stake in GLS Pharma

Aurobindo Pharma Limited — US FDA issues Form 483 with seven observations to Aurobindo's Telangana plant

Common Questions — Cefixime Suppliers from India

Q Which cefixime supplier from India is the most reliable for bulk orders?

Q How many cefixime manufacturers are there in India?

Q What certifications should I verify?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Lupin Limited — Lupin's subsidiary Multicare plans new product launches in FY25 and FY26

Q What is the typical price range for cefixime from India?

Analysis Methodology